Company Filing History:
Years Active: 2008
Title: Jerome Stephens: Innovator in Biosynthetic Pathways
Introduction
Jerome Stephens is a notable inventor based in Mentone, Alabama, recognized for his contributions to the field of biosynthetic pathways. He holds a patent that significantly advances the understanding and production of LL-F28249 compounds, which are of great interest in the pharmaceutical industry.
Latest Patents
Jerome's patent focuses on the complete biosynthetic pathway for the formation of LL-F28249 compounds, particularly the major component LL-F28249α. The invention details a purified and isolated nucleic acid molecule that encodes the proteins necessary for this biosynthetic pathway. This pathway is compactly organized within three plasmids, enabling efficient production of natural metabolites and semisynthetic derivatives. The patent also covers plasmids, vectors, and host cells that express the novel nucleic acid molecule, as well as the purified biosynthesis proteins encoded by the DNA gene cluster.
Career Highlights
Jerome Stephens is associated with Wyeth, a company known for its innovative pharmaceutical products. His work has contributed to advancements in the production of highly active natural metabolites, showcasing his expertise in biochemistry and molecular biology.
Collaborations
Jerome has collaborated with notable coworkers, including Chengjin Huang and Deborah Tardy Chaleff, who have contributed to the research and development of his patented technologies.
Conclusion
Jerome Stephens stands out as an inventor whose work in biosynthetic pathways has the potential to impact the pharmaceutical industry significantly. His innovative approach to the production of LL-F28249 compounds exemplifies the importance of research and collaboration in advancing scientific knowledge.